NFH
RIGL icon

NEXT Financial Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

NEXT Financial Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$5K Buy
+195
New +$4.46K ﹤0.01% 1270

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

NEXT Financial Holdings's RIGL Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Rigel Pharmaceuticals (RIGL) in Q1 2019: 195 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #1270 among its holdings.

131 funds tracked by Wall St. Rank hold RIGL as of Q1 2019.

  • NEXT Financial Holdings held 195 shares of Rigel Pharmaceuticals worth $5K as of Q1 2019.
  • Rigel Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
  • Rigel Pharmaceuticals made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1270 holding.
  • 131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.